Registry for ME/CFS patients in Germany
Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)
Technical University of Munich · NCT05778006
This study is creating a large registry to collect health information from people of all ages with ME/CFS in Germany, especially those affected by long-term COVID-19 effects, to help improve understanding and treatment of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 650 (estimated) |
| Ages | 0 Years and up |
| Sex | All |
| Sponsor | Technical University of Munich (other) |
| Locations | 1 site (Munich, Bavaria) |
| Trial ID | NCT05778006 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a large-scale registry to collect data on the epidemiology, phenotypes, and disease trajectories of ME/CFS in Germany. It focuses on individuals of all ages affected by ME/CFS, particularly in the context of long-term effects following COVID-19 and other viral infections. The registry will facilitate future clinical trials by providing valuable insights into the condition and its management. The study will include patients diagnosed with ME/CFS based on established international criteria and will gather comprehensive health data.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with ME/CFS based on internationally recognized criteria.
Not a fit: Patients who do not have a diagnosis of ME/CFS or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of ME/CFS and lead to improved diagnosis and treatment options for patients.
How similar studies have performed: While there have been various studies on ME/CFS, this registry approach is relatively novel and aims to fill gaps in existing knowledge.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ME/CFS diagnosis (ICD-10 G93.3) based on internationally established criteria * Informed consent by patients and/or guardian(s) Exclusion Criteria: * No ME/CFS (ICD-10 G93.3) * No informed consent
Where this trial is running
Munich, Bavaria
- MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital — Munich, Bavaria, Germany (RECRUITING)
Study contacts
- Principal investigator: Uta Behrends, Prof. Dr. med. — MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
- Study coordinator: Uta Behrends, Prof. Dr. med.
- Email: uta.behrends@tum.de
- Phone: +4989 30682632
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: ME/CFS, CFS/ME, ME/CFS Following EBV-associated Infectious Mononucleosis, ME/CFS Following COVID-19, SARS-CoV-2, COVID-10, Post-COVID-19 condition, Chronic fatigue syndrome